|
|
Press Releases - 2004
Gamida-Cell Reports Complete Safety and Efficacy Results of Phase I/II Study of StemEx® for the Treatment of Leukemia
Dec. 6, 2004
| Results encourage Gamida-Cell to push for pivotal Phase III Study of StemEx® to begin in 2005 and fast track designation
|
Gamida-Cell's Phase I/II IND Study Results Indicate StemEx® for the Treatment of Leukemia to be Safe & Efficacious
Nov. 15, 2004
Gamida-Cell to Present Phase I/II Study Results of StemEx® for the Treatment of Leukemia in an Oral Presentation at the 2004 Annual Meeting of the American Society of Hematology (ASH)
Oct. 28, 2004
| Recent data from the pre-clinical cardiac program also to be delivered |
Gamida-Cell’s Pre-Clinical Study Demonstrates that Expanded Populations of Human Bone Marrow Stem Cells May Effectively Treat Heart Attacks Results to be presented on September 30th, 2004, 2 p.m. at Bio Japan, at the New Takanawa Prince Hotel in Shinagawa, Tokyo
Sep. 21, 2004
Gamida-Cell Completes Enrollment in its Phase I/II Trial of StemEx® for the Treatment of Leukemia
Aug. 2, 2004
| Pre-Clinical Stem Cell Expansion Study Results, Supporting the Company’s current Leukemia Clinical Study, Published in the August Issue of Cytotherapy |
Gamida-Cell To Present Stem Cell Therapy: From Vision to Therapeutics, Multiple Uses for Cord Blood Bank Units
Jun. 15, 2004
| At the Israel-China Bio-Tech & Venture Capital Conference
Presentations scheduled for June 22nd in Beijing and June 24th in Shanghai
|
Gamida-Cell’s Groundbreaking Stem Cell Expansion Study Results to be Published in June Issue of Experimental Hematology
Jun. 3, 2004
| Data the Basis for the Current IND Phase I/II study of StemEx®
for the Treatment of Leukemia Currently in Progress in the U.S. |
Gamida-Cell’s Early Pre-clinical Studies Indicate Expanded Population of Stem Cells Successfully Reverses Diabetes
May. 27, 2004
| CEO to present findings at Medtech’s Investment in Innovation, June 8, 2004 |
Gamida-Cell Awarded $1.3 Million Grant From the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor, Israel (OCS)
May. 17, 2004
| OCS approves total budget of $3 million for stem cell projects in 2004 |
Gamida-Cell TEPA Study Results Provide More Strong Scientific Support for the Company’s Current Phase I/II Leukemia Trial in the U.S.
May. 10, 2004
| Research results published in the March 2004 issue of Leukemia and Lymphoma |
Gamida-Cell Study Data Shows that Expanded Populations of Stem Cells Are Efficient in Treating Heart Disease
Apr. 28, 2004
| Three sets of pre-clinical results to be presented at the 10th Annual Meeting of the International Society for Cellular Therapy (ISCT) 2004 in Dublin
|
|
Press Releases Archive
•
•
•
•
•
•
•
|
